Erin P. Ward
( out of 93 reviews )

Erin P. Ward, MD

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

1950 Circle of Hope
Salt Lake City , UT 84112
801-587-4415
Get Directions

Erin Ward

Erin P. Ward, MD is a surgical oncologist who specializes in the treatment of patients with abdominal cancers. She specializes in the surgical management of appendix cancer, neuroendocrine tumors, gastric cancer, and metastatic colorectal cancer. She is an expert in the treatment of peritoneal surface malignancies and other cancers that may have spread to the peritoneal lining, including the use of advanced therapies such as cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

Dr. Ward is an Assistant Professor at the University of Utah; prior to joining she trained with world-renowned experts at the Medical College of Wisconsin and the University of California San Diego. Dr. Ward grew up in Michigan where she earned her medical degree at the College of Human Medicine at Michigan State University. She completed her general surgery residency and a two-year research fellowship at the University of California San Diego. She completed her training with a two-year Complex Surgical Oncology and completed an AHPBA Certified hepato-pancreatic biliary surgery fellowship at the Medical College of Wisconsin. She is board certified in both general surgery and complex general surgical oncology.

Dr. Ward is one of two Commission on Cancer Liaison Physicians at the Huntsman Cancer Institute and actively pursuing research to understand better the impact of psychosocial health on cancer patient outcomes and patient-reported outcomes.

Dr. Ward’s primary research focus is defining the impact of psychosocial health on the long-term and short-term outcomes for cancer patients.

Dr. Ward’s clinical interests include:

  • Metastatic colorectal cancer
  • Appendiceal cancer
  • Gastric cancer
  • Neuroendocrine tumors
  • Minimally invasive surgery
  • Mesothelioma
  • Peritoneal based malignancies
  • HIPEC

Specialties

Board Certification

American Board of Surgery (Sub: Complex General Surgical Oncology)
American Board of Surgery

Patient Rating

5.0 /5
( out of 93 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

Erin P. Ward, MD is a surgical oncologist who specializes in the treatment of patients with abdominal cancers. She specializes in the surgical management of appendix cancer, neuroendocrine tumors, gastric cancer, and metastatic colorectal cancer. She is an expert in the treatment of peritoneal surface malignancies and other cancers that may have spread to the peritoneal lining, including the use of advanced therapies such as cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

Dr. Ward is an Assistant Professor at the University of Utah; prior to joining she trained with world-renowned experts at the Medical College of Wisconsin and the University of California San Diego. Dr. Ward grew up in Michigan where she earned her medical degree at the College of Human Medicine at Michigan State University. She completed her general surgery residency and a two-year research fellowship at the University of California San Diego. She completed her training with a two-year Complex Surgical Oncology and completed an AHPBA Certified hepato-pancreatic biliary surgery fellowship at the Medical College of Wisconsin. She is board certified in both general surgery and complex general surgical oncology.

Dr. Ward is one of two Commission on Cancer Liaison Physicians at the Huntsman Cancer Institute and actively pursuing research to understand better the impact of psychosocial health on cancer patient outcomes and patient-reported outcomes.

Dr. Ward’s primary research focus is defining the impact of psychosocial health on the long-term and short-term outcomes for cancer patients.

Dr. Ward’s clinical interests include:

  • Metastatic colorectal cancer
  • Appendiceal cancer
  • Gastric cancer
  • Neuroendocrine tumors
  • Minimally invasive surgery
  • Mesothelioma
  • Peritoneal based malignancies
  • HIPEC

Board Certification and Academic Information

Academic Departments Surgery -Assistant Professor (Clinical)
Academic Divisions Surgical Oncology
Board Certification
American Board of Surgery (Sub: Complex General Surgical Oncology)
American Board of Surgery

Education history

Undergraduate Physiology - Michigan State University B.S.
Undergraduate Psychology; Specialization in Bioethics, Humanities and Society - Michigan State University B.S.
Professional Medical Medicine - Michigan State University College of Human Medicine M.D.
Residency General Surgery - University of California, San Diego School of Medicine Resident
Research Fellow Surgical Oncology - University of California, San Diego School of Medicine Research Fellow
Chief Resident General Surgery - University of California, San Diego School of Medicine Administrative Chief Resident
Fellowship Hepato-Pancreato-Biliary - Medical College of Wisconsin Fellow
Fellowship Complex General Surgical Oncology - Medical College of Wisconsin Fellow

Selected Publications

Journal Article

  1. Ward EP, Okamuro L, Khan S, Hosseini M, Valasek MA, Ronquillo N Jr, Kelly KJ, Veerapong J, Lowy AM, Baumgartner J (2021). Ki67 does not predict recurrence for low-grade appendiceal mucinous neoplasms with peritoneal dissemination after cytoreductive surgery and HIPEC. Hum Pathol, 113, 104-110.
  2. Weiss A, Lopez NE, Ward EP, Lee KC, Caudle AS, Dickson-Witmer D, Chang C, Kelly K, Martin LW, Jacobs LK, Hunt KK, Yao K, Blair SL (2019). Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC). Ann Surg Oncol, 26(13), 4364-4371.
  3. DeLong JC, Ward EP, Lwin TM, Brumund KT, Kelly KJ, Horgan S, Bouvet M (2018). Indocyanine green fluorescence-guided parathyroidectomy for primary hyperparathyroidism. Surgery, 163(2), 388-392.
  4. Voss RK, Ward EP, Ojeda-Fournier H, Blair SL (2018). Doppler Ultrasound-Visible SignalMark Microspheres are Better Identified than HydroMARK® Clips in a Simulated Intraoperative Setting in Breast and Lung Tissue. Ann Surg Oncol, 25(12), 3740-3746.
  5. Ward EP, Yang J, Delong JC, Sung TW, Wang J, Barback C, Mendez N, Horgan S, Trogler W, Kummel AC, Blair SL (2018). Identifying lost surgical needles with visible and near infrared fluorescent light emitting microscale coating. Surgery, 163(4), 883-888.
  6. Ward EP, Wang A, Thangarajah H, Lazar D, Bickler S, Fairbanks T, Kling KM (2017). Preemptive Ladd Procedure in congenital diaphragmatic hernia and Abdominal Wall defects does not reduce the risk of future volvulus. J Pediatr Surg, 52(12), 1956-1961.
  7. Ward EP, Unkart JT, Bryant A, Murphy J, Blair SL (2017). Influence of Distance to Hospital and Insurance Status on the Rates of Contralateral Prophylactic Mastectomy, a National Cancer Data Base study. Ann Surg Oncol, 24(10), 3038-3047.
  8. Ward EP, Weiss A, Blair SL (2017). Incidence and treatments of DCIS in octogenarians: grade matters. Breast Cancer Res Treat, 165(2), 403-409.
  9. Ward EP, Shiavazzi D, Sood D, Marsden A, Lane J, Owens E, Barleben A (2017). Computed Tomography Fractional Flow Reserve Can Identify Culprit Lesions in Aortoiliac Occlusive Disease Using Minimally Invasive Techniques. Ann Vasc Surg, 38, 151-157.
  10. Ward EP, Wang J, Mendez N, Yang J, Barback C, Wang-Rodriguez J, Trogler W, Kummel AC, Blair S (2016). Utilization of iron (III)-doped nanoshells for in vivo marking of nonpalpable tumors using a VX2 rabbit model. Am J Surg, 212(6), 1140-1146.
  11. Wang A, Prieto JM, Ward E, Bickler S, Henry M, Kling K, Thangarajah H, Ignacio R Jr (2019). Operative treatment for intussusception: Should an incidental appendectomy be performed? J Pediatr Surg, 54(3), 495-499.
  12. Langness S, Ward E, Halbach J, Lizardo R, Davenport K, Bickler S, Kling K, Thangarajah H, Grabowski J, Fairbanks T (2018). Plasma D-dimer safely reduces unnecessary CT scans obtained in the evaluation of pediatric head trauma. J Pediatr Surg, 53(4), 752-757.
  13. Badaracco AG, Ward E, Barback C, Yang J, Wang J, Huang CH, Kim M, Wang Q, Nam S, Delong J, Blair S, Trogler WC, Kummel A (2020). Indocyanine green modified silica shells for colon tumor marking. Appl Surf Sci, 499.
  14. Yang J, Ward E, Sung TW, Wang J, Barback C, Mendez N, Blair S, Trogler WC, Kummel AC (2017). Silica Shells/Adhesive Composite Film for Color Doppler Ultrasound Guided Needle Placement. ACS Biomater Sci Eng, 3(8), 1780-1787.
  15. Yang J, Wang J, Ta CN, Ward E, Barback CV, Sung TW, Mendez N, Blair SL, Kummel AC, Trogler WC (2017). Ultrasound Responsive Macrophase-Segregated Microcomposite Films for in Vivo Biosensing. ACS Appl Mater Interfaces, 9(2), 1719-1727.
  16. Weiss A, Lee KC, Romero Y, Ward E, Kim Y, Ojeda-Fournier H, Einck J, Blair SL (2014). Calcifications on mammogram do not correlate with tumor size after neoadjuvant chemotherapy. Ann Surg Oncol, 21(10), 3310-6.
  17. Robles J, Weiss A, Ward EP, Unkart J, Blair SL (2016). Treatment of Breast Cancer in Women Aged 80 and Older: A Systematic Review. Breast Cancer: Current Research, 1(4).
  18. Ward EP, Vincent-Sheldon S, Tolat P, Kulkarni N, Aldakkak M, Budithi R, Clarke CN, Tsai S, Evans DB, Christians K (2024). Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomy. Surgery,
  19. Graves A, Sadjadi J, Kosich M, Ward E, Sood D, Fahy B, Pankratz S, Mishra SI, Greenbaum (2024). Decision Regret in Patients with Appendiceal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Annals of surgical oncology, 31(12), 7978-7986.
  20. Clarke CN, Ward E, Henry V, Nimmer K, Phan A, Evans D (2024). Impact of Regional Metastasis on Survival for Patients with Nonfunctional Pancreatic Neuroendocrine Tumors: A Systematic Review. Annals of surgical oncology, 31(8), 4976-4985.
  21. Bansal VV, Godfrey EL, Sadjadi J, Bello RJ, Kwakman R, Abreu AA, Vudatha V, Sparkman BK, Freudenberger DC, Su DG, Turaga KK, Micic D, Malec M, Tun S, Polite B, Lambert LA, Greenbaum A, Gunderson CG, Smith TJ, Kopecky KE, Powers BD, Maduekwe UN, Ward EP, Peritoneal Surface Malignancies (PSM) Consortium Grou (2025). Consensus Guideline for the Management of Malignant Gastrointestinal Obstruction in Patients with Peritoneal Surface Malignancies. Annals of surgical oncology,
  22. Brown LM, Wilkins SG, Bansal VV, Su DG, Gomez-Mayorga J, Turaga KK, Gunderson CG, Lee B, Nash GM, Hays JL, Raghav KP, Husain AL, Kluger MD, Zauderer MG, Kindler HL, Alexander HR, Peritoneal Surface Malignancies (PSM) Consortium Grou (2025). Consensus Guideline for the Management of Peritoneal Mesothelioma. Annals of surgical oncology,
  23. Godfrey EL, Mahoney F, Bansal VV, Su DG, Hanna DN, Lopez-Ramirez F, Baron E, Turaga KK, Benson AB 3rd, Cusack J, Winer JH, Gunderson CG, Misdraji J, Shah R, Magge DR, Solsky I, Eng C, Eng OS, Shergill A, Shen JP, Foote MB, Peritoneal Surface Malignancies (PSM) Consortium Grou (2025). Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement. Annals of surgical oncology,
  24. Butensky SD, Bansal VV, Su DG, Waheed MT, Nikiforchin A, Gomez-Mayorga JL, Olecki E, Radomski SN, Sun B, Turaga KK, Gunderson CG, Lacy J, Badgwell BD, In H, Kennedy T, Yoon HH, Greer JB, Sundar R, Woo Y, Peritoneal Surface Malignancies (PSM) Consortium Grou (2025). Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases. Annals of surgical oncology,
  25. Schultz KS, Bansal VV, Wach MM, Bhutiani N, Godley FA 4th, Wang JJ, Waheed MT, Buchheit JT, Papai E, Campbell S, Schleimer LE, Su DG, Turaga KK, Gunderson CG, White MG, Uppal A, Raghav KPS, Labow DM, Sarpel U, Shergill AP, Shen JP, Eng C, Foote MB, Baumgartner JM, Peritoneal Surface Malignancies (PSM) Consortium Grou (2025). Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases. Annals of surgical oncology,
  26. Su DG, Brown LM, Bansal VV, Bakkila B, Concors SJ, Turaga KK, Gunderson C, Bergsland E, Strosberg JR, Halfdanarson TR, Metz DC, Kunstman JW, Kunz PL, Gangi A, Peritoneal Surface Malignancies (PSM) Consortium Grou (2025). Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms. Annals of surgical oncology,
  27. Godfrey EL, Mahoney F, Bansal VV, Su DG, Hanna DN, Lopez-Ramirez F, Baron E, Turaga KK, Benson AB 3rd, Setia N, Winer JH, Gunderson CG, Shah R, Magge DR, Solsky I, Eng C, Eng OS, Shergill A, Shen JP, Misdraji J, Foote MB, Luo W, Peritoneal Surface Malignancies Consortium Grou (2025). Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement. Cancer, 131(13), e35874.

Review

  1. Ward EP, Zeh Iii HJ, Tsai S (2021). Current Controversies in Neoadjuvant Therapy for Pancreatic Cancer. [Review]. Surg Oncol Clin N Am, 30, (4), 657-671.
  2. Ward EP, Evans DB, Tsai S (2021). Ten-year experience in optimizing neoadjuvant therapy for localized pancreatic cancer-Medical college of Wisconsin perspective. [Review]. J Surg Oncol, 123, (6), 1405-1413.
  3. Holowatyj AN, Overman MJ, Votanopoulos KI, Lowy AM, Wagner P, Washington MK, Eng C, Foo WC, Goldberg RM, Hosseini M, Idrees K, Johnson DB, Shergill A, Ward E, Zachos NC, Shelton D, Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundatio (2025). Defining a 'cells to society' research framework for appendiceal tumours. Nature reviews. Cancer, 25(4), 293-315.

Case Report

  1. Weiss A, Ward EP, Baumgartner JM, Lowy AM, Kelly KJ (2018). Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients. World J Surg Oncol, 16(1), 87.
  2. Halbach J, Ward E, Langness S, Davenport K, Bickler SW, Fairbanks T, Kling K (2017). Gallbladder Polyps in Children: A Painful Inflammatory Process. Am Surg, 83(4), e140-142.

Editorial

  1. Cortina CS, Ward EP, Kong AL (2021). The consideration for outpatient mastectomy during the COVID-19 global pandemic. Am J Surg, 222(2), 290-291.
  2. Ward EP, Greenbaum (2024). Exploring the Patient Experience Through Qualitative Methods: The Missing Piece of Cytoreductive Surgery and HIPEC Research. Annals of surgical oncology,
  3. Bansal VV, Witmer HDD, Childers CP, Su DG, Turaga KK, RVU Writing Group, PSM Consortium Grou (2025). When Benchmarks Fail Us: A Case Study in Cytoreductive Surgery. Annals of surgical oncology, 32(1), 19-23.

Abstract

  1. Sood, DJ, Ward, E (2024). Evaluating the impact of depression on self-reported quality of life measurements for patients with a history of cancer: A 2022 behavioral risk factor surveillance system questionnaire study.

News & Podcasts

Huntsman Cancer Institute News

Podcasts